<DOC>
	<DOCNO>NCT00857987</DOCNO>
	<brief_summary>Evaluate improvement common cold use medication</brief_summary>
	<brief_title>Effectiveness Safety Guaifenesin , Doxylamine Succinate Hydrochloride Etafedrine Syrup Improvement Symptoms Resulting From Acute Respiratory Infections .</brief_title>
	<detailed_description>Patients sign symptom URI forward Research Center screen researcher select meet inclusion criterion . This visit inform objective study , methodology , risk benefit , right patient give research , confidentiality data detail provide patient consider participation basement viable . All aspect relevant consideration patient participation describe Informed Consent , read signed procedure . The patient include randomize , open treatment immediately send perform radiological examination ( Rx - sinus face ) . This examination use detect clinical picture URI . After 24 hour ( visit 02 ) , patient return assessment clinical question symptom , provide score efficacy product . This visit review radiological examination , find infection sinus without symptom , patient exclude antibiotic use begin . In return three day ( visit 03 ) , patient evaluate relation clinical status . On visit , doctor may take follow behavior : - Patients clinical symptom get high . - Patients improve , take dose medicine increase . - The worsening present , due infection bacterial clinical picture , exclude refer general practitioner employ sponsor . In return seven day , patient return product participate clinical consultation , researcher may take follow behavior : - Patients clinical symptom get high . - Patients improve worsen exempt study refer general practitioner hire sponsor repeat diagnosis establish new treatment . Will allow use rescue medication paracetamol sodium dipyrone , justify existence placebo group product interfere result evaluate , pain antipyretic .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Expectorants</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Doxylamine</mesh_term>
	<mesh_term>Doxylamine succinate</mesh_term>
	<criteria>Patients take part study , agree term propose FICT ; Patients age 12 year ethnicity , class social group ; Patients sex ; Patients good mental health ; Patient acute respiratory disease upper airways viral etiology ( URI ) ; Patient early sign symptom URI minimum time failure great 48 hour . Patients treat antibiotic predict use antibiotic clinical condition ; Presence bacterial table upper airway lung ( bacterial sinusitis , pneumonia , etc. ) . Patient cystic fibrosis ; Primary metastatic cancer lung ; Presence respiratory table 14 day duration ; Treatment immunosuppressive drug ; Presence medical psychological condition , discretion investigator , prevent patient study ; History abuse alcohol drug ; Participation clinical trial six month precede study ; Patients severe pulmonary disease , require multidrug treatment ; Presence concomitant pulmonary disease ; Pregnancy lactation ; History hypersensitivity drug pharmacological class substance investigation .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>IRA , Guaifenesin , Etaphedrine , Doxilamine</keyword>
</DOC>